<DOC>
	<DOCNO>NCT00755560</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness albendazole treatment asymptomatic infection parasite Toxocara child . Treatment response define reduction number eosinophils blood . The study drug compare placebo randomly assign double blind manner . Follow prospective . 50 child ( 25 per group ) enrol study .</brief_summary>
	<brief_title>Treatment Asymptomatic Toxocariasis With Albendazole Children</brief_title>
	<detailed_description />
	<mesh_term>Toxocariasis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>Pediatric ambulatory patient asymptomatic toxocariasis Children 2 15 year old Absolute eosinophil count &gt; 1100 / mm3 Normal ophthalmoscopy Treatment benzimidazole previous year Infection nematode ( Ascaris lumbricoides , strongyloides stercoralis , uncinarias , Trichuris trichuria ) Symptomatic patient ( prolonged fever , acute pneumonitis , hepatomegaly , splenomegaly , ocular compromise due toxocara ) Concomitant disease Immunocompromised patient Altered liver kidney function Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Toxocara</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Albendazole</keyword>
	<keyword>eosinophilia</keyword>
	<keyword>parasitology</keyword>
	<keyword>pediatric clinical pharmacology</keyword>
</DOC>